| Year |
Citation |
Score |
| 2024 |
Hsu EJ, Lin TA, Dabush DR, McCaw Z, Koong A, Lin C, Abi Jaoude J, Patel R, Kouzy R, El Alam MB, Noticewala S, Yang Y, Sherry AD, Fuller CD, Thomas CR, ... ... Ludmir EB, et al. Association of differential censoring with survival and suboptimal control arms among oncology clinical trials. Journal of the National Cancer Institute. PMID 38331394 DOI: 10.1093/jnci/djae028 |
0.367 |
|
| 2024 |
Yang Y, Jayaraj S, Ludmir E, Roberts K. Text Classification of Cancer Clinical Trial Eligibility Criteria. Amia ... Annual Symposium Proceedings. Amia Symposium. 2023: 1304-1313. PMID 38222417 |
0.449 |
|
| 2024 |
Ludmir EB, Hoffman KE, Jhingran A, Kouzy R, Ip MP, Sturdevant L, Ning MS, Minsky BD, McAleer MF, Chronowski GM, Arzu IY, Reed VK, Garg AK, Roberts T, Eastwick GA, et al. Implementation and Efficacy of a Large-Scale Radiation Oncology Case-Based Peer-Review Quality Program across a Multinational Cancer Network. Practical Radiation Oncology. PMID 38176466 DOI: 10.1016/j.prro.2023.12.007 |
0.667 |
|
| 2023 |
Waldhorn I, Bomze D, Ben-Aharon I, Schlosser S, Markel G, Ludmir EB, Meirson T. Gender Gap in Leadership of Clinical Trials. Jama Internal Medicine. PMID 37902723 DOI: 10.1001/jamainternmed.2023.5104 |
0.419 |
|
| 2023 |
Sherry AD, Msaouel P, McCaw ZR, Abi Jaoude J, Hsu EJ, Kouzy R, Patel R, Yang Y, Lin TA, Taniguchi CM, Rödel C, Fokas E, Tang C, Fuller CD, Minsky B, ... ... Ludmir EB, et al. Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy. European Journal of Cancer (Oxford, England : 1990). 194: 113357. PMID 37827064 DOI: 10.1016/j.ejca.2023.113357 |
0.74 |
|
| 2023 |
Lin TA, Sherry AD, Ludmir EB. Challenges, Complexities, and Considerations in the Design and Interpretation of Late-Phase Oncology Trials. Seminars in Radiation Oncology. 33: 429-437. PMID 37684072 DOI: 10.1016/j.semradonc.2023.06.007 |
0.405 |
|
| 2023 |
Corrigan KL, Rooney MK, Kouzy R, Manzar G, Thomas CR, Ludmir EB. Selection and Prejudice: Addressing Clinical Trial Disparities With a Review of Current Shortcomings and Future Directions. Seminars in Radiation Oncology. 33: 367-373. PMID 37684066 DOI: 10.1016/j.semradonc.2023.06.002 |
0.77 |
|
| 2023 |
Rooney MK, Sharifi B, Ludmir EB, Fuller CD, Warner JL. Factors Associated With Altmetric Attention Scores for Randomized Phase III Cancer Clinical Trials. Jco Clinical Cancer Informatics. 7: e2300082. PMID 37552823 DOI: 10.1200/CCI.23.00082 |
0.419 |
|
| 2023 |
Sherry AD, Corrigan KL, Kouzy R, Jaoude JA, Yang Y, Patel RR, Totten DJ, Newman NB, Das P, Taniguchi C, Minsky B, Snyder RA, Fuller CD, Ludmir E. Prevalence, trends, and characteristics of trials investigating local therapy in contemporary phase 3 clinical cancer research. Cancer. PMID 37382235 DOI: 10.1002/cncr.34929 |
0.769 |
|
| 2023 |
Florez MA, Jaoude JA, Patel RR, Kouzy R, Lin TA, De B, Beck EJ, Taniguchi CM, Minsky BD, Fuller CD, Lee JJ, Kupferman M, Raghav KP, Overman MJ, Thomas CR, ... Ludmir EB, et al. Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials. Jama Network Open. 6: e2313819. PMID 37195664 DOI: 10.1001/jamanetworkopen.2023.13819 |
0.75 |
|
| 2023 |
Das A, Lin TA, Lin C, Meirson T, McCaw ZR, Tian L, Ludmir EB. Assessment of Median and Mean Survival Time in Cancer Clinical Trials. Jama Network Open. 6: e236498. PMID 37010873 DOI: 10.1001/jamanetworkopen.2023.6498 |
0.435 |
|
| 2022 |
Corrigan KL, Kouzy R, Jaoude JA, Patel RR, Layman RM, Giordano SH, Woodward WA, Smith BD, Shaitelman SF, Ludmir EB. Inclusion of premenopausal women in breast cancer clinical trials. Breast (Edinburgh, Scotland). 66: 204-207. PMID 36327626 DOI: 10.1016/j.breast.2022.10.013 |
0.746 |
|
| 2022 |
Diefenhardt M, Martin D, Ludmir EB, Fleischmann M, Hofheinz RD, Ghadimi M, Kosmala R, Polat B, Friede T, Minsky BD, Rödel C, Fokas E. Development and Validation of a Predictive Model for Toxicity of Neoadjuvant Chemoradiotherapy in Rectal Cancer in the CAO/ARO/AIO-04 Phase III Trial. Cancers. 14. PMID 36139585 DOI: 10.3390/cancers14184425 |
0.32 |
|
| 2022 |
Koay EJ, Zaid M, Aliru M, Bagereka P, Van Wieren A, Rodriguez MJ, Jacobson G, Wolff RA, Overman M, Varadhachary G, Pant S, Wang H, Tzeng CW, Ikoma N, Kim M, ... ... Ludmir EB, et al. Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients with Locally Advanced and Borderline Resectable Pancreatic Cancer: Phase I Trial and Imaging-based Biomarker Validation. International Journal of Radiation Oncology, Biology, Physics. PMID 35863672 DOI: 10.1016/j.ijrobp.2022.06.089 |
0.356 |
|
| 2022 |
Bumanlag IM, Jaoude JA, Rooney MK, Taniguchi CM, Ludmir EB. Exclusion of Older Adults from Cancer Clinical Trials: Review of the Literature and Future Recommendations. Seminars in Radiation Oncology. 32: 125-134. PMID 35307114 DOI: 10.1016/j.semradonc.2021.11.003 |
0.486 |
|
| 2022 |
Patel RR, Parisi R, Verma V, Kouzy R, Abi Jaoude J, Lin TA, Fuller CD, VanderWalde NA, Jagsi R, Smith BD, Guadagnolo BA, Thomas CR, Ludmir EB. Association between Prior Malignancy Exclusion Criteria and Age Disparities in Cancer Clinical Trials. Cancers. 14. PMID 35205795 DOI: 10.3390/cancers14041048 |
0.768 |
|
| 2021 |
Abi Jaoude J, Thunshelle CP, Kouzy R, Nguyen ND, Lin D, Prakash L, Bumanlag IM, Noticewala SS, Niedzielski JS, Beddar S, Ludmir EB, Holliday EB, Das P, Minsky BD, Herman JM, et al. Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era. Advances in Radiation Oncology. 6: 100763. PMID 34934858 DOI: 10.1016/j.adro.2021.100763 |
0.681 |
|
| 2021 |
Corrigan KL, Kry S, Howell RM, Kouzy R, Jaoude JA, Patel RR, Jhingran A, Taniguchi C, Koong AC, McAleer MF, Nitsch P, Rödel C, Fokas E, Minsky BD, Das P, ... ... Ludmir EB, et al. The Radiotherapy Quality Assurance Gap Among Phase III Cancer Clinical Trials. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 34838891 DOI: 10.1016/j.radonc.2021.11.018 |
0.756 |
|
| 2021 |
Abi Jaoude J, Kouzy R, Rooney M, Thompson P, Patel R, Turner MC, Ghabach M, Fuller CD, Minsky BD, Taniguchi CM, Ludmir EB. Impact factor and citation metrics in phase III cancer trials. Oncotarget. 12: 1780-1786. PMID 34504650 DOI: 10.18632/oncotarget.28044 |
0.746 |
|
| 2021 |
Fokas E, Appelt A, Glynne-Jones R, Beets G, Perez R, Garcia-Aguilar J, Rullier E, Joshua Smith J, Marijnen C, Peters FP, van der Valk M, Beets-Tan R, Myint AS, Gerard JP, Bach SP, ... ... Ludmir E, et al. International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer. Nature Reviews. Clinical Oncology. PMID 34349247 DOI: 10.1038/s41571-021-00538-5 |
0.315 |
|
| 2021 |
Metzger AL, Kusi Appiah A, Wright CM, Jairam V, Amini A, Park HS, Welsh JW, Thomas CR, Verma V, Ludmir EB. Financial Relationships Between Industry and Principal Investigators of United States Cooperative Group Randomized Cancer Clinical Trials. International Journal of Cancer. PMID 34173669 DOI: 10.1002/ijc.33719 |
0.396 |
|
| 2021 |
Abi Jaoude J, Kouzy R, Ghabach M, Patel R, Pasalic D, Ghossain E, Miller AB, Lin TA, Verma V, Fuller CD, Subbiah V, Minsky BD, Ludmir EB, Taniguchi CM. Food and Drug Administration approvals in phase 3 Cancer clinical trials. Bmc Cancer. 21: 695. PMID 34118915 DOI: 10.1186/s12885-021-08457-5 |
0.736 |
|
| 2021 |
Pasalic D, Fuller CD, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Grossberg AJ, Jagsi R, Das P, Koong AC, Rödel C, Fokas E, Thomas CR, Minsky BD, ... Ludmir EB, et al. Detecting the Dark Matter of Unpublished Clinical Cancer Studies: An Analysis of Phase 3 Randomized Controlled Trials. Mayo Clinic Proceedings. 96: 420-426. PMID 33549260 DOI: 10.1016/j.mayocp.2020.08.015 |
0.578 |
|
| 2020 |
De B, Kaiser KW, Ludmir EB, Yeboa DN, Tang C, Hoffman KE, Liao Z, Koong AC, Smith BD. Radiotherapy clinical trial enrollment during the COVID-19 pandemic. Acta Oncologica (Stockholm, Sweden). 1-4. PMID 33356801 DOI: 10.1080/0284186X.2020.1865564 |
0.451 |
|
| 2020 |
Patel RR, Verma V, Fuller CD, McCaw ZR, Ludmir EB. Transparency in reporting of phase 3 cancer clinical trial results. Acta Oncologica (Stockholm, Sweden). 1-4. PMID 33307924 DOI: 10.1080/0284186X.2020.1856410 |
0.634 |
|
| 2020 |
Grant SR, Lin TA, Miller AB, Mainwaring W, Espinoza AF, Jethanandani A, Walker GV, Smith BD, Ashleigh Guadagnolo B, Jagsi R, David Fuller C, Thomas CR, Ludmir EB. Racial and Ethnic Disparities Among Participants in US-Based Phase 3 Randomized Cancer Clinical Trials. Jnci Cancer Spectrum. 4: pkaa060. PMID 33225207 DOI: 10.1093/jncics/pkaa060 |
0.422 |
|
| 2020 |
Abi Jaoude J, Kouzy R, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Pasalic D, Verma V, VanderWalde NA, Smith BD, Smith GL, Fuller CD, Das P, Minsky BD, ... ... Ludmir EB, et al. Performance Status Restriction in Phase III Cancer Clinical Trials. Journal of the National Comprehensive Cancer Network : Jnccn. 18: 1322-1326. PMID 33022640 DOI: 10.1200/Jco.2020.38.15_Suppl.2059 |
0.794 |
|
| 2020 |
Abi Jaoude J, Kouzy R, El Alam MB, Subbiah V, Taniguchi CM, Ludmir EB, Lin TA. Exclusion of Older Adults in COVID-19 Clinical Trials. Mayo Clinic Proceedings. 95: 2293-2294. PMID 33012364 DOI: 10.1016/j.mayocp.2020.08.018 |
0.697 |
|
| 2020 |
Lin TA, Fuller CD, Verma V, Mainwaring W, Espinoza AF, Miller AB, Jethanandani A, Pasalic D, Das P, Minsky BD, Thomas CR, Fogelman DR, Subbiah V, Subbiah IM, Ludmir EB. Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials. Cancers. 12. PMID 32947844 DOI: 10.3390/Cancers12092636 |
0.606 |
|
| 2020 |
Kouzy R, Abi Jaoude J, Minsky BD, Das P, Koong AC, Subbiah IM, Ludmir EB, Taniguchi CM. Gastrointestinal malignancies and supportive care trials: a snapshot of the last two decades. Bmj Supportive & Palliative Care. PMID 32943466 DOI: 10.1136/Bmjspcare-2020-002538 |
0.751 |
|
| 2020 |
Ludmir EB, McCaw ZR, Fuller CD, Wei LJ. Progression-free survival in the ICON8 trial. Lancet (London, England). 396: 756. PMID 32919510 DOI: 10.1016/S0140-6736(20)31175-2 |
0.485 |
|
| 2020 |
Fuller CD, van Dijk LV, Thompson RF, Scott JG, Ludmir EB, Thomas CR. Meeting the Challenge of Scientific Dissemination in the Era of COVID-19: Toward a Modular Approach to Knowledge-Sharing for Radiation Oncology. International Journal of Radiation Oncology, Biology, Physics. 108: 496-505. PMID 32890543 DOI: 10.1016/J.Ijrobp.2020.06.066 |
0.646 |
|
| 2020 |
Kouzy R, Abi Jaoude J, Lin D, Nguyen ND, El Alam MB, Ludmir EB, Taniguchi CM. Patient-Reported Outcome Measures in Pancreatic Cancer Receiving Radiotherapy. Cancers. 12. PMID 32887363 DOI: 10.3390/Cancers12092487 |
0.706 |
|
| 2020 |
Kouzy R, Abi Jaoude J, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Verma V, Fuller CD, Minsky BD, Rödel C, Taniguchi CM, Ludmir EB. Professional Medical Writer Assistance in Oncology Clinical Trials. The Oncologist. PMID 32885898 DOI: 10.1634/Theoncologist.2020-0406 |
0.757 |
|
| 2020 |
Pasalic D, Tang C, Jagsi R, Fuller CD, Koong AC, Ludmir EB. Association of Industry Sponsorship With Cancer Clinical Trial Accrual. Jama Oncology. PMID 32815984 DOI: 10.1001/Jamaoncol.2020.1284 |
0.606 |
|
| 2020 |
Kouzy R, Abi Jaoude J, Yue J, Maldonado JA, Taniguchi CM, Ludmir EB, Colbert LE. Applying to Radiation Oncology Amid a Pandemic. Advances in Radiation Oncology. 5: 777-779. PMID 32775792 DOI: 10.1016/J.Adro.2020.06.017 |
0.639 |
|
| 2020 |
Pasalic D, McGinnis GJ, Fuller CD, Grossberg AJ, Verma V, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Diefenhardt M, Das P, Subbiah V, Subbiah IM, Jagsi R, ... ... Ludmir EB, et al. Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials. European Journal of Cancer (Oxford, England : 1990). 136: 176-185. PMID 32702645 DOI: 10.1016/J.Ejca.2020.06.015 |
0.458 |
|
| 2020 |
Kouzy R, Abi Jaoude J, Garcia Garcia CJ, El Alam MB, Taniguchi CM, Ludmir EB. Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic. Jama Network Open. 3: e2015100. PMID 32658285 DOI: 10.1001/jamanetworkopen.2020.15100 |
0.736 |
|
| 2020 |
Diefenhardt M, Ludmir EB, Hofheinz RD, Ghadimi M, Minsky BD, Rödel C, Fokas E. Association of Treatment Adherence With Oncologic Outcomes for Patients With Rectal Cancer: A Post Hoc Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial. Jama Oncology. PMID 32644104 DOI: 10.1001/jamaoncol.2020.2394 |
0.449 |
|
| 2020 |
Abi Jaoude J, Kouzy R, Minsky BD, Fuller CD, Yuan Y, Do KA, Taniguchi CM, Ludmir EB. Sponsor-Involved Statistical Analyses in Phase III Cancer Clinical Trials. International Journal of Cancer. PMID 32621758 DOI: 10.1002/Ijc.33180 |
0.793 |
|
| 2020 |
Abi Jaoude J, Kouzy R, Nguyen ND, Lin D, Noticewala SS, Ludmir EB, Taniguchi CM. Radiation therapy for patients with locally advanced pancreatic cancer: Evolving techniques and treatment strategies. Current Problems in Cancer. 100607. PMID 32471736 DOI: 10.1016/J.Currproblcancer.2020.100607 |
0.672 |
|
| 2020 |
Pasalic D, Ludmir EB, Allen PK, Thaker NG, Chapman BV, Hanna EY, Su SY, Ferrarotto R, Glisson BS, Reddy JP, Brandon Gunn G, Fuller CD, Phan J, Rosenthal DI, Morrison WH, et al. Patient-Reported Outcomes, Physician-Reported Toxicities, and Treatment Outcomes in a Modern Cohort of Patients with Sinonasal Cancer Treated Using Proton Beam Therapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 32417351 DOI: 10.1016/J.Radonc.2020.05.007 |
0.418 |
|
| 2020 |
Colbert LE, Kouzy R, Abi Jaoude J, Ludmir EB, Taniguchi CM. Cancer Research after COVID-19: Where Do We Go from Here? Cancer Cell. 37: 637-638. PMID 32396859 DOI: 10.1016/J.Ccell.2020.04.003 |
0.669 |
|
| 2020 |
Fokas E, Glynne-Jones R, Appelt A, Beets-Tan R, Beets G, Haustermans K, Marijnen C, Minsky BD, Ludmir E, Quirke P, Sebag-Montefiore D, Garcia-Aguilar J, Gambacorta MA, Valentini V, Buyse M, et al. Outcome measures in multimodal rectal cancer trials. The Lancet. Oncology. 21: e252-e264. PMID 32359501 DOI: 10.1016/S1470-2045(20)30024-3 |
0.584 |
|
| 2020 |
Corrigan KL, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Piotrowski M, Fuller CD, Stauder MC, Shaitelman SF, Perkins GH, Woodward WA, Giordano SH, Smith BD, Ludmir EB. Exclusion of Men from Randomized Phase III Breast Cancer Clinical Trials. The Oncologist. PMID 32272505 DOI: 10.1634/theoncologist.2019-0871 |
0.545 |
|
| 2020 |
Grant SR, Noticewala SS, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Gunn GB, Fuller CD, Thomas CR, Portelance L, Ludmir EB. Non-English language validation of patient-reported outcome measures in cancer clinical trials. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 32189098 DOI: 10.1007/s00520-020-05399-9 |
0.597 |
|
| 2020 |
Patel RR, Ludmir EB, Augustyn A, Zaorsky NG, Lehrer EJ, Ryali R, Trifiletti DM, Adeberg S, Amini A, Verma V. De-intensification of therapy in human papillomavirus associated oropharyngeal cancer: A systematic review of prospective trials. Oral Oncology. 103: 104608. PMID 32163853 DOI: 10.1016/j.oraloncology.2020.104608 |
0.357 |
|
| 2020 |
Pasalic D, Betancourt-Cuellar SL, Taku N, Ludmir EB, Lu Y, Allen PK, Tang C, Antonoff MB, Fuller CD, Rosenthal DI, Morrison WH, Phan J, Garden AS, Welsh JW, Chang JY, et al. Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer. Head & Neck. PMID 32129548 DOI: 10.1002/Hed.26117 |
0.429 |
|
| 2020 |
Patel RR, Verma V, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Mainwaring W, Augustyn A, Fuller CD, Sulman EP, Yeboa DN, Chung CC, McAleer MF, Li J, Yoshor D, ... ... Ludmir EB, et al. Exclusion of Patients with Brain Metastases from Cancer Clinical Trials. Neuro-Oncology. PMID 31900480 DOI: 10.1093/Neuonc/Noz246 |
0.581 |
|
| 2020 |
Jaoude JA, Kouzy R, Mainwaring W, Lin T, Miller AB, Jethanandani A, Espinoza AF, Taniguchi CM, Ludmir EB. Professional medical writing assistance in oncology clinical trials. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E14088 |
0.676 |
|
| 2020 |
Jaoude JA, Kouzy R, Mainwaring W, Lin T, Miller AB, Jethanandani A, Espinoza AF, Ludmir EB, Taniguchi CM. The landscape of gastrointestinal oncologic phase III clinical trials in the last two decades. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E14087 |
0.738 |
|
| 2020 |
Noticewala SS, Patel RR, Ludmir EB. Absence of optimism bias in industry-sponsored cancer trials. Journal of Clinical Oncology. 38: 2020-2020. DOI: 10.1200/jco.2020.38.15_suppl.2020 |
0.385 |
|
| 2020 |
Kouzy R, Jaoude JA, El Alam M, Mainwaring W, Lin T, Miller A, Jethanandani A, Espinoza A, Ludmir E, Taniguchi C. Phase III Radiation Oncology Clinical Trials: A Snapshot of the Last Two Decades International Journal of Radiation Oncology*Biology*Physics. 108: e788-e789. DOI: 10.1016/j.ijrobp.2020.07.259 |
0.751 |
|
| 2020 |
Grant S, Mainwaring W, Lin T, Miller A, Jethanandani A, Espinoza A, Ludmir E. Racial Disparities among Participants in US-Based Cancer Clinical Trials International Journal of Radiation Oncology*Biology*Physics. 108: e382-e383. DOI: 10.1016/j.ijrobp.2020.07.2407 |
0.476 |
|
| 2020 |
Pasalic D, Ludmir E, Thaker N, Gunn B, Hanna E, Su S, Ferrarotto R, Glisson B, Reddy J, Fuller C, Phan J, Rosenthal D, Morrison W, Garden A, Frank S. Prospective Patient-Reported Outcomes, Physician-Assessed Toxicities, and Treatment Outcomes in Sinonasal Malignancies Following Proton Beam Therapy International Journal of Radiation Oncology Biology Physics. 108. DOI: 10.1016/J.Ijrobp.2020.02.498 |
0.457 |
|
| 2019 |
Diefenhardt M, Ludmir EB, Hofheinz RD, Ghadimi M, Minsky BD, Rödel C, Fokas E. Association of Sex With Toxic Effects, Treatment Adherence, and Oncologic Outcomes in the CAO/ARO/AIO-94 and CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trials of Rectal Cancer. Jama Oncology. PMID 31804659 DOI: 10.1001/jamaoncol.2019.5102 |
0.464 |
|
| 2019 |
Ludmir EB, McCaw ZR, Grossberg AJ, Wei LJ, Fuller CD. Quantifying the benefit of non-small-cell lung cancer immunotherapy. Lancet (London, England). 394: 1904. PMID 31777387 DOI: 10.1016/S0140-6736(19)32503-6 |
0.402 |
|
| 2019 |
Ludmir EB, Espinoza AF, Jethanandani A, Lin TA, Mainwaring W, Miller AB, Das P. Incidence and Correlates of HIV Exclusion Criteria in Cancer Clinical Trials. International Journal of Cancer. PMID 31746465 DOI: 10.1002/ijc.32800 |
0.358 |
|
| 2019 |
Ludmir EB, Subbiah IM, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Mandel JJ, Fang P, Smith BD, Smith GL, Pinnix CC, Sedrak MS, Kimmick GG, Stinchcombe TE, et al. Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials. Journal of Geriatric Oncology. PMID 31711757 DOI: 10.1016/J.Jgo.2019.11.001 |
0.591 |
|
| 2019 |
Ludmir EB, Espinoza AF, Jethanandani A, Lin TA, Mainwaring W, Miller AB, Das P. Reporting and Exclusion of Sexual and Gender Minorities in Cancer Clinical Trials. International Journal of Cancer. PMID 31584188 DOI: 10.1002/ijc.32700 |
0.373 |
|
| 2019 |
Ludmir EB, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Holliday EB. Women's Representation Among Lead Investigators of Clinical Trials in Oncology. Jama Oncology. PMID 31393530 DOI: 10.1001/jamaoncol.2019.2196 |
0.316 |
|
| 2019 |
Ludmir EB, Fuller CD, Moningi S, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Verma V, Smith BD, Smith GL, VanderWalde NA, Holliday EB, Guadagnolo BA, Stinchcombe TE, et al. Sex-Based Disparities Among Cancer Clinical Trial Participants. Journal of the National Cancer Institute. PMID 31350545 DOI: 10.1093/Jnci/Djz154 |
0.579 |
|
| 2019 |
Ludmir EB, Jethanandani A, Mainwaring W, Miller AB, Lin TA, Espinoza AF, Grossberg AJ, Fuller CD. Assessing the Impact of Complementary and Alternative Medicine Trials in Oncology. Integrative Cancer Therapies. 18: 1534735419859089. PMID 31220950 DOI: 10.1177/1534735419859089 |
0.53 |
|
| 2019 |
Ludmir EB, Jethanandani A, Mainwaring W, Miller AB, Lin TA, Espinoza AF, Verma V, VanderWalde NA, Grossberg AJ, Guadagnolo BA, Koong AC, Jagsi R, Thomas CR, Fuller CD. The Trials (and Tribulations) of Complementary and Alternative Medicine in Oncology. Journal of the National Cancer Institute. PMID 31165160 DOI: 10.1093/Jnci/Djz117 |
0.572 |
|
| 2019 |
Ludmir EB, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Mandel JJ, Lin SH, Smith BD, Smith GL, VanderWalde NA, Minsky BD, Koong AC, Stinchcombe TE, Jagsi R, et al. Factors Associated With Age Disparities Among Cancer Clinical Trial Participants. Jama Oncology. PMID 31158272 DOI: 10.1001/Jamaoncol.2019.2055 |
0.557 |
|
| 2019 |
Ludmir EB, Adlakha EK, Chun SG, Reed VK, Arzu IY, Ahmad N, Bloom E, Chronowski GM, Delclos ME, Mayo LL, Schlembach PJ, Liao Z, Koong AC, Herman JM, Shah SJ. Enhancing clinical trial enrollment at MD Anderson Cancer Center satellite community campuses. Acta Oncologica (Stockholm, Sweden). 1-3. PMID 30958082 DOI: 10.1080/0284186X.2019.1600019 |
0.429 |
|
| 2019 |
Ludmir EB, Mandel JJ, McAleer MF, de Groot JF. Disparities along the glioblastoma clinical trials landscape. Neuro-Oncology. 21: 285-286. PMID 30476295 DOI: 10.1093/Neuonc/Noy176 |
0.434 |
|
| 2019 |
Gjyshi O, Ludmir EB, Pezzi TA, Boyce-Fappiano D, Mitin T, Lin SH. Nationwide shift in patterns of prophylactic cranial irradiation utilization for extensive-stage small cell lung cancer patients. Journal of Clinical Oncology. 37: e20099-e20099. DOI: 10.1200/JCO.2019.37.15_SUPPL.E20099 |
0.402 |
|
| 2019 |
Ludmir EB, Mainwaring W, Miller AB, Lin T, Jethanandani A, Espinoza AF, Fuller CD. Age disparities among cancer clinical trial participants: The role of industry sponsorship. Journal of Clinical Oncology. 37: 11527-11527. DOI: 10.1200/Jco.2019.37.15_Suppl.11527 |
0.606 |
|
| 2019 |
Youssef M, Ludmir E, Mandel J, Patel A, Jalali A, Treiber J, Wu J, McAleer M, DeGroot J. HOUT-18. TREATMENT STRATEGIES FOR GLIOBLASTOMA IN OLDER PATIENTS: AGE IS JUST A NUMBER Neuro-Oncology. 21: vi115-vi116. DOI: 10.1093/Neuonc/Noz175.483 |
0.379 |
|
| 2019 |
Ludmir E, Moningi S, Mainwaring W, Miller A, Lin T, Jethanandani A, Espinoza A, Buszek S, Pinnix C, Das P, Woodward W, Guadagnolo B, Herman J, Koong A, Jagsi R, et al. Women’s Representation among Lead Investigators of Clinical Trials in Oncology International Journal of Radiation Oncology*Biology*Physics. 105: E465-E466. DOI: 10.1016/J.Ijrobp.2019.06.1430 |
0.587 |
|
| 2018 |
Mandel JJ, Youssef M, Ludmir E, Yust-Katz S, Patel A, de Groot JF. Highlighting the need for reliable clinical trials in glioblastoma. Expert Review of Anticancer Therapy. PMID 29973092 DOI: 10.1080/14737140.2018.1496824 |
0.44 |
|
| 2017 |
Ng SP, Ludmir EB, Oyervides MA, Wu RY, Frank S, Gunn GB. Combination Intensity Modulated Proton Therapy and Passive Scatter Boost for Rapidly Progressing Nasal Cavity Squamous Cell Carcinoma. Cureus. 9: e1685. PMID 29152442 DOI: 10.7759/Cureus.1685 |
0.571 |
|
| 2017 |
Ludmir EB, Palta M, Willett CG, Czito BG. Total neoadjuvant therapy for rectal cancer: An emerging option. Cancer. 123: 1497-1506. PMID 28295220 DOI: 10.1002/cncr.30600 |
0.378 |
|
| 2017 |
Ludmir EB, Kachnic LA, Czito BG. Evolution and Management of Treatment-Related Toxicity in Anal Cancer. Surgical Oncology Clinics of North America. 26: 91-113. PMID 27889040 DOI: 10.1016/j.soc.2016.07.004 |
0.328 |
|
| 2016 |
Keehn A, Ludmir E, Taylor J, Rabbani F. Incidence of bladder cancer after radiation for prostate cancer as a function of time and radiation modality. World Journal of Urology. PMID 27629559 DOI: 10.1007/S00345-016-1934-Z |
0.355 |
|
| 2015 |
Ludmir EB, Arya R, Wu Y, Palta M, Willett CG, Czito BG. Role of Adjuvant Radiotherapy in Locally Advanced Colonic Carcinoma in the Modern Chemotherapy Era. Annals of Surgical Oncology. PMID 26480849 DOI: 10.1245/s10434-015-4907-3 |
0.407 |
|
| Show low-probability matches. |